Utilization of intravenous bisphosphonates in patients with bone metastases secondary to breast, lung, or prostate cancer

@inproceedings{Hagiwara2013UtilizationOI,
  title={Utilization of intravenous bisphosphonates in patients with bone metastases secondary to breast, lung, or prostate cancer},
  author={May Hagiwara and Thomas E Delea and Ze Cong and Karen C. Chung},
  booktitle={Supportive Care in Cancer},
  year={2013}
}
Cancer patients with bone metastases (BMets) are predisposed to skeletal complications. Bone-targeted therapies such as denosumab or intravenous bisphosphonates (IVBs) reduce the risk of these complications. This study characterized patterns of IVB use in these patients in the USA. This was a retrospective, observational study using the Truven Health… CONTINUE READING